Onze-Lieve-Vrouwziekenhuis — Clinical Trial Site

60 Registered trials

16 Currently recruiting

Organisation

Onze-Lieve-Vrouwziekenhuis

Location

Aalst, Belgium

Identifier

ORG-100029942

Address

Moorselbaan 164, 9300, Belgium

Departments

AZORG
cardiology
Cardiovascular Center
Department of Cardiology
Department of pulmonary medicine
Endocrinologie
Endocrinology
Gastro-enterology
Gastroenterology
Intensive care
Internal Medicine
Medical Oncology
Medical Oncology Department
N/A
Nephrology
Oncology
Pneumologie
Pneumologie-Respiratoire Oncologie
Pneumology
Pneumology department
Pulmonology
Radiation Oncology
Radiotherapy-Oncology
Rheumatology
Urologie
Urology
Urology department

Clinical trials at this site (60)

Search interface

A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
Study to compare overall survival (OS) between subjects who receive SBP-101 and those who do not receive SBP-101 (i.e., placebo) in combinat… Ended

2024-514714-12-00 Metastatic Pancreatic Ductal Adenocarcinoma 10 2022-11-11
A study to learn how well the treatment combination of finerenone and empagliflozin works and how safe it is compared to each treatment alon… Ended

2023-506981-30-00 Chronic kidney disease in type 2 diabetes mellitus 4 2022-05-25
Stereotactic body radiotherapy with or without Darolutamide for OligoRecurrent prostate cancer: a randomized phase II trial (DART) Ended

2024-511140-37-00 OligoRecurrent prostate cancer 4 2021-02-12
A Study of Tiragolumab in Combination with Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin versus Pembrolizumab Plus Pemetrexed and C… Ended

2022-502031-20-00 Non-squamous non-small cell lung cancer (NSCLC) 10 2020-12-17
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CV… Ended

2023-507846-96-00 Type 2 Diabetes Mellitus 5 2020-06-19
Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer Ended

2022-501972-25-00 Locally Advanced Cervical Cancer 5 2020-04-06
A study to Evaluate Patisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy Ended

2023-508364-29-00 Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amy 5 2019-11-22
A Long-term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICKHCM (MY… Ended

2022-502858-14-00 Hypertrophic cardiomyopathy 5 2019-09-05
RCT part: COBRA-Slim with or without fast access to TNF blockade for remission induction in early RA. LTE part: Long Term observational fol… Ended

2023-510189-28-00 Rheumatoid Arthritis 6 2018-05-15
A Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Urothelial Cancer Ended

2023-510296-56-00 Advanced Urothelial Cancer 5 2018-03-26
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan… Ended

2023-506487-13-00 Hormone receptor-positive, her2-negative advanced/metas 5